October 29, 2020

Connecting the Dots on Digital Health Webinar Series: Part 3 - Payment, FDA, Public Policy and Advocacy Considerations

Thursday, October 29

12:00 PM - 1:00 PM CST

In this session we will explore the regulatory hurdles innovator companies must overcome to bring a digital health product to market, including the path to FDA clearance, quality measure requirements, and coding, coverage and payment issues. We will outline key strategic considerations for digital health innovators, including pricing, clinical research design, stakeholder consensus, and coalition building. This session will include helpful issue checklists and employ common digital health scenarios to illustrate legal and advocacy concepts.

Click here to register.